General AML

ESH 2019 | Can genetic testing predict AML risk in healthy individuals?

L:

The AML Global Portal were delighted to speak to Liran Shlush, Weizmann Institute of Science, Rehovot, IL, during the European School of Hematology (ESH) Translational Research Conference on AML. We asked Liran Shlush: Can genetic testing predict AML risk in healthy individuals?

Liran Shlush discusses the current methods being developed to predict AML such as blood tests and molecular testing (Deep sequencing of targeted genes), which will possibly enable identification of healthy individual at high risk of developing AML by using a mathematical model. Liran Shlush explains the future implication of clinical trials being designed to enrol healthy, high-risk individuals to receive preventative therapy.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!